ALLR vs TXT · P/E 0.0, rev $25.0K vs P/E 19, rev $7.52B
Allarity Therapeutics Inc (ALLR) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the ALLR and TXT stock pages for the full models.
Not investment advice.